CoChat

Schistosoma mansoni secretes a chemokine binding protein with antiinflammatory activity

Open access
Smith, Philip, Fallon, Rosie E., Mangan, Niamh E., Walsh, Caitriona M., Saraiva, Margarida, Sayers, Jon R., McKenzie, Andrew N.J., Alcami, Antonio, Fallon, Padraic G. · 2005 · The Journal of Experimental Medicine

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Abstract

The coevolution of humans and infectious agents has exerted selective pressure on the immune system to control potentially lethal infections. Correspondingly, pathogens have evolved with various strategies to modulate and circumvent the host's innate and adaptive immune response. Schistosoma species are helminth parasites with genes that have been selected to modulate the host to tolerate chronic worm infections, often for decades, without overt morbidity. The modulation of immunity by schistosomes has been shown to prevent a range of immune-mediated diseases, including allergies and autoimmunity. Individual immune-modulating schistosome molecules have, therefore, therapeutic potential as selective manipulators of the immune system to prevent unrelated diseases. Here we show that S. mansoni eggs secrete a protein into host tissues that binds certain chemokines and inhibits their interaction with host chemokine receptors and their biological activity. The purified recombinant S. mansoni chemokine binding protein (smCKBP) suppressed inflammation in several disease models. smCKBP is unrelated to host proteins and is the first described chemokine binding protein encoded by a pathogenic human parasite and may have potential as an antiinflammatory agent.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.20050955

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Presence of a CKBP in S. mansoni ES. (A) Cercarial homogenates (1) or homogenates (2, 4, and 6) or secretions (3, 5, and 7) from schistosomula (2 and 3), worms (4 and 5), or eggs (6 and 7) or binding media (8) were cross-linked to 125I-CXCL8 or 125I-CCL3. All schistosome antigen preparations had nonspecific binding (*) to iodinated chemokines (55–60 kD) that was also detectable in the binding media. (B) CXCL8 and CCL3 binding to U937 cells in the presence of a range of protein concentrations of homogenates (open circles and dotted line) or secretions (closed circles and continuous line) from different life cycle stages of S. mansoni. (C) Cross-linking of 125I-CXCL8 or 125I-CCL3 to binding media (1 and 4) or smCKBP in the absence (2 and 5) or presence (3 and 6) of excess unlabeled chemokine. (D) Anti-smCKBP rabbit sera probe of Western blot of homogenates of S. mansoni cercariae (1), schistosomula (2), worms (3), and eggs (4), S. japonicum eggs (5), S. haematobium eggs (6), or secretions from S. mansoni schistosomula (7), worms (8), or eggs (9).
Figure 1. Presence of a CKBP in S. mansoni ES. (A) Cercarial homogenates (1) or homogenates (2, 4, and 6) or secretions (3, 5, and 7) from schistosomula (2 and 3), worms (4 and 5), or eggs (6 and 7) or binding media (8) were cross-linked to 125I-CXCL8 or 125I-CCL3. All schistosome antigen preparations had nonspecific binding (*) to iodinated chemokines (55–60 kD) that was also detectable in the binding media. (B) CXCL8 and CCL3 binding to U937 cells in the presence of a range of protein concentrations of homogenates (open circles and dotted line) or secretions (closed circles and continuous line) from different life cycle stages of S. mansoni. (C) Cross-linking of 125I-CXCL8 or 125I-CCL3 to binding media (1 and 4) or smCKBP in the absence (2 and 5) or presence (3 and 6) of excess unlabeled chemokine. (D) Anti-smCKBP rabbit sera probe of Western blot of homogenates of S. mansoni cercariae (1), schistosomula (2), worms (3), and eggs (4), S. japonicum eggs (5), S. haematobium eggs (6), or secretions from S. mansoni schistosomula (7), worms (8), or eggs (9).CC BY-NC-SA · PubMed Central
Figure 2. r-smCKBP is a functional CKBP. (A) Silver-stained SDS-PAGE gel of natural or r-smCKBP. Western blot of SDS-PAGE resolved natural (line 1) and r-smCKBP (line 2) probed with anti-smCKBP antisera or NRS. (B) r-smCKBP was cross-linked to 125I-chemokines with or without competing cold chemokines. (C) Binding of 125I-CXCL8 and 125I-CCL3 to U937 cells after preincubation with r-smCKBP (red filled circles and line) or with a control protein (CRD, open circles and continuous line). (D) Migration of human neutrophils in response to CXCL8 preincubated with r-smCKBP (red bars) or with control CRD (open bars). Migration was also elicited with 100 nM n-FMLP preincubated with 1,000 ng/ml of r-smCKBP or CRD. The values shown represent means ± SD from triplicate samples. (E) CCL5-induced activation (Ca2+ flux) of human PBMCs from three donors treated with r-smCKBP (red filled circles and line) or control CRD (open circles and continuous line). Data are representative of two to four separate experiments.
Figure 2. r-smCKBP is a functional CKBP. (A) Silver-stained SDS-PAGE gel of natural or r-smCKBP. Western blot of SDS-PAGE resolved natural (line 1) and r-smCKBP (line 2) probed with anti-smCKBP antisera or NRS. (B) r-smCKBP was cross-linked to 125I-chemokines with or without competing cold chemokines. (C) Binding of 125I-CXCL8 and 125I-CCL3 to U937 cells after preincubation with r-smCKBP (red filled circles and line) or with a control protein (CRD, open circles and continuous line). (D) Migration of human neutrophils in response to CXCL8 preincubated with r-smCKBP (red bars) or with control CRD (open bars). Migration was also elicited with 100 nM n-FMLP preincubated with 1,000 ng/ml of r-smCKBP or CRD. The values shown represent means ± SD from triplicate samples. (E) CCL5-induced activation (Ca2+ flux) of human PBMCs from three donors treated with r-smCKBP (red filled circles and line) or control CRD (open circles and continuous line). Data are representative of two to four separate experiments.CC BY-NC-SA · PubMed Central
Figure 3. r-smCKBP inhibits inflammation in vivo. (A) In an air pouch model, r-smCKBP treatment significantly inhibits CXCL8-induced neutrophil infiltration (P < 0.001). The percentages of neutrophils on cytospins are shown as means ± SEM (n = 4–6) and are representative of two separate experiments. (B) r-smCKBP inhibits inflammation in a contact hypersensitivity model. DNFB–sensitized mice were injected intravenously with r-smCKBP or CRD before application of DNFB solution. Data are presented as means ± SE of ear thickness (n = 6–8 mice). Significantly reduced inflammation was observed in mice treated with r-smCKBP 24 h after DNFB exposure (P < 0.001 by Student's t test). (C) Representative cross sections of ears and cytospins of the pinnae infiltrate (H&E stained). Data are representative of three separate experiments. (D) r-smCKBP blocks CXCL8-induced pulmonary neutrophilia. Mice were treated intranasally (i.n.) with CXCL8 or PBS or were injected intravenous (i.v.) with r-smCKBP or PBS. 18 h later, whole-body plethysmography was used to determine lung function (Penh) and bronchoalveolar lavage (BAL) fluid recovered for total cell counts and flow cytometry for neutrophil infiltration. Statistical values represent differences between CXCL8 + PBS–treated and CXCL8 + r-smCKBP–treated groups by Student's t test. All data represent means ± SE from four to seven mice per group. Data are representative of two separate experiments.
Figure 3. r-smCKBP inhibits inflammation in vivo. (A) In an air pouch model, r-smCKBP treatment significantly inhibits CXCL8-induced neutrophil infiltration (P < 0.001). The percentages of neutrophils on cytospins are shown as means ± SEM (n = 4–6) and are representative of two separate experiments. (B) r-smCKBP inhibits inflammation in a contact hypersensitivity model. DNFB–sensitized mice were injected intravenously with r-smCKBP or CRD before application of DNFB solution. Data are presented as means ± SE of ear thickness (n = 6–8 mice). Significantly reduced inflammation was observed in mice treated with r-smCKBP 24 h after DNFB exposure (P < 0.001 by Student's t test). (C) Representative cross sections of ears and cytospins of the pinnae infiltrate (H&E stained). Data are representative of three separate experiments. (D) r-smCKBP blocks CXCL8-induced pulmonary neutrophilia. Mice were treated intranasally (i.n.) with CXCL8 or PBS or were injected intravenous (i.v.) with r-smCKBP or PBS. 18 h later, whole-body plethysmography was used to determine lung function (Penh) and bronchoalveolar lavage (BAL) fluid recovered for total cell counts and flow cytometry for neutrophil infiltration. Statistical values represent differences between CXCL8 + PBS–treated and CXCL8 + r-smCKBP–treated groups by Student's t test. All data represent means ± SE from four to seven mice per group. Data are representative of two separate experiments.CC BY-NC-SA · PubMed Central
Figure 4. Secretion of smCKBP from live eggs in vitro and in vivo. (A) Precipitate formation (arrows) around live eggs cultured in vitro with anti-smCKBP sera but not NRS. (B) Detection of smCKBP (brown stain) within the granulomas surrounding eggs in liver or intestines of infected mice. Bar, 50 μm.
Figure 4. Secretion of smCKBP from live eggs in vitro and in vivo. (A) Precipitate formation (arrows) around live eggs cultured in vitro with anti-smCKBP sera but not NRS. (B) Detection of smCKBP (brown stain) within the granulomas surrounding eggs in liver or intestines of infected mice. Bar, 50 μm.CC BY-NC-SA · PubMed Central
Figure 5. Blocking smCKBP in vitro increases the pulmonary granulomatous inflammation to live eggs. (A) Rabbit anti-smCKBP sera dose-dependently blocks r-smCKBP activity in vitro. Different dilutions, in triplicate, of NRS (open circles and continuous line) and anti-smCKBP sera (red filled circles and line) were incubated with r-smCKBP before addition of 125I-CXCL8. Samples were then tested in a U937 cell binding assay. Data are presented relative to 100% blocking of 125I-CXCL8 cell binding by r-smCKBP. (B) Sections of lungs showing granuloma around eggs (arrow) in lungs of mice treated with NRS or anti-smCKBP sera as stained by H&E. Bar, 50 μm. (C) Size of egg granuloma in lungs of mice treated with NRS or anti-smCKBP sera. The values shown represent means ± SD. (D) High magnification of cells within granuloma around eggs (top right, arrows) in lungs of mice treated with NRS or anti-smCKBP sera. Bar, 10 μm. (E) Cell composition of pulmonary granulomas around eggs in lungs of mice treated with NRS or anti-smCKBP sera. Data represent means ± SD from six mice per group and are representative of two separate experiments. Student's t test was used to test for statistical differences between groups, and p-values are shown.
Figure 5. Blocking smCKBP in vitro increases the pulmonary granulomatous inflammation to live eggs. (A) Rabbit anti-smCKBP sera dose-dependently blocks r-smCKBP activity in vitro. Different dilutions, in triplicate, of NRS (open circles and continuous line) and anti-smCKBP sera (red filled circles and line) were incubated with r-smCKBP before addition of 125I-CXCL8. Samples were then tested in a U937 cell binding assay. Data are presented relative to 100% blocking of 125I-CXCL8 cell binding by r-smCKBP. (B) Sections of lungs showing granuloma around eggs (arrow) in lungs of mice treated with NRS or anti-smCKBP sera as stained by H&E. Bar, 50 μm. (C) Size of egg granuloma in lungs of mice treated with NRS or anti-smCKBP sera. The values shown represent means ± SD. (D) High magnification of cells within granuloma around eggs (top right, arrows) in lungs of mice treated with NRS or anti-smCKBP sera. Bar, 10 μm. (E) Cell composition of pulmonary granulomas around eggs in lungs of mice treated with NRS or anti-smCKBP sera. Data represent means ± SD from six mice per group and are representative of two separate experiments. Student's t test was used to test for statistical differences between groups, and p-values are shown.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Research works printed but not linked: 1

  1. 2000, Eur. J. Immunol., 30, 470, 10.1002/1521-4141(200002)30:2<470::AID-IMMU470>3.0.CO;2-T · doi:10.1002/1521-4141(200002)30:2<470::aid-immu470>3.0.co;2-t

Cited by

See all 160

Metadata

Authors
Smith, P., Fallon, R. E., Mangan, N. E., Walsh, C. M., Saraiva, M., Sayers, J. R., McKenzie, A. N. J., Alcami, A., & Fallon, P. G.
Affiliations
  • Trinity College Dublin (IE)
  • 1School of Biochemistry and Immunology, Trinity College, Dublin 2, Ireland
  • University of Cambridge (GB)
  • University of Sheffield (GB)
  • MRC Laboratory of Molecular Biology (GB)
  • 2Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge CBQ 2QQ, England, UK
Venue
The Journal of Experimental Medicine
Published
2005-11-21
Volume
202
Issue
10
Pages
1319-1325
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W2142867136
Cited by
160
References
24
Citations by year
2026: 4 · 2025: 2 · 2024: 3 · 2023: 6 · 2022: 5 · 2021: 10 · 2020: 16 · 2019: 5 · 2018: 10 · 2017: 4 · 2016: 7 · 2015: 8 · 2014: 6 · 2013: 6 · 2012: 11
FWCI
6.35
Type
journal article
Language
en
Open access
Locations
  • The Journal of Experimental Medicine (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • Arrow@dit (Dublin Institute of Technology) (acceptedVersion)
  • Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion, cc-by-nc-sa)
Funders
  • Wellcome Trust
  • Irish Research Council for Science, Engineering and Technology
  • Science Foundation Ireland
  • Irish Research Council
Topics
  • Life Sciences › Immunology and Microbiology › Parasitology › Parasites and Host Interactions
  • Health Sciences › Medicine › Infectious Diseases › Parasitic Diseases Research and Treatment
  • Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Mollusks and Parasites Studies
Keywords
Schistosoma mansoni, chemokine binding protein, schistosome eggs, chemokine receptor inhibition, anti-inflammatory activity, immunomodulation, helminths, inflammation reduction, parasite secreted proteins, host-parasite coevolution
MeSH terms
Animals, Disease Models, Animal, Female, Humans, Intestines, Liver, Mice, Inbred BALB C, Ovum, Schistosoma mansoni, Schistosomiasis mansoni, Helminth Proteins, Inflammation Mediators, Chemokines, Proteomics, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Schistosoma mansoni secretes a chemokine binding protein with antiinflammatory activity. https://app.cochat.ai/papers/10.1084/jem.20050955
The paper
Smith, P., Fallon, R. E., Mangan, N. E., Walsh, C. M., Saraiva, M., Sayers, J. R., McKenzie, A. N. J., Alcami, A., & Fallon, P. G. (2005). Schistosoma mansoni secretes a chemokine binding protein with antiinflammatory activity. The Journal of Experimental Medicine. https://doi.org/10.1084/jem.20050955

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.